Global Health Limited has informed the Exchange about Presentation
MEDANTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Global Health Limited (Medanta) filed a revised investor presentation for Q4 and FY2025, with changes to slides 13, 19, 22, and 26 to reflect the merger of its wholly-owned subsidiary MHPL (Lucknow unit) with the holding company, effective April 1, 2024. For FY2025, consolidated total income rose 12.6% year-on-year to INR 37,714 million, driven by patient volume growth, while EBITDA grew 9.4% to INR 9,562 million with margins at 25.4%. Profit after tax stood at INR 4,813 million, impacted by a one-time INR 499 million exceptional merger expense; adjusted PAT grew 8.5% to INR 5,186 million. The company declared its first-ever dividend of INR 0.50 per share (25%). Occupied bed days grew 10% and 219 new beds were added during the year, taking total installed beds to 3,042. The company plans over INR 3,500 crores in capex over the next five years to add roughly 3,000 more beds across Noida, Mumbai, Delhi, South Delhi, and Guwahati.
Shareholders benefit from the first-ever dividend, continued volume-led growth, and a strong net cash position of INR 8,123 million supporting expansion. The one-time merger expense slightly suppressed reported PAT but underlying growth remains healthy, with capacity expansion likely to drive future revenue.